Learn About Large-Cell Immunoblastic Lymphoma

What is the definition of Large-Cell Immunoblastic Lymphoma?
A diffuse large B-cell lymphoma characterized by the presence of immunoblasts with uniformly round-to-oval nuclei, a prominent nucleolus, and abundant cytoplasm.
Save information for later
Sign Up
What are the alternative names for Large-Cell Immunoblastic Lymphoma?
  • Lymphoma, large-cell, immunoblastic
  • Large cell immunoblastic lymphoma
Who are the top Large-Cell Immunoblastic Lymphoma Local Doctors?
Learn about our expert tiers
Learn more
What are the latest Large-Cell Immunoblastic Lymphoma Clinical Trials?
Phase I Trial of Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

Background: Non-Hodgkin lymphoma (NHL) is the most common cancer among people living with HIV in the United States. People with HIV are up to 17 times more likely to get NHL than people who do not have HIV. The disease may also be different in these two groups. More study is needed for treating people with both HIV and NHL.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Phase II Study of Dose-Adjusted EPOCH+/-Rituximab in Adults With Untreated Burkitt Lymphoma, c-MYC Positive Diffuse Large B-Cell Lymphoma and Plasmablastic Lymphoma

Background: Burkitt lymphoma/leukemia (BL) is highly treatable, but most of the standard therapies require multiple doses of intensive chemotherapy that may require long hospital stays and frequently have severe side effects. In addition, BL is a fairly common type of cancer in patients who also have human immunodeficiency virus (HIV), but treatment outcomes are poor because standard treatments do not work ve...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Large-Cell Immunoblastic Lymphoma?

There is no recent research available for this condition. Please check back because thousands of new papers are published every week and we strive to find and display the most recent relevant research as soon as it is available.